Concussion Prevention and Management
OFA Committment to High Performance Athletes
February 21, 2009
- The Ontario Fencing Association (OFA) is fully committed to financially and otherwise supporting Ontario High Performance Fencers to achieve optimum success nationally and internationally, within the limits of available resources.
- For Provincial purposes, a High Performance athlete is defined as one who is striving for success at an international level, within an organized Provincial Team program.
- The OFA is committed to transparency in all its dealings with athletes and other members. For each funding program, criteria will be developed by the High Performance Committee, within an overall budget approved by the OFA Board of Directors. Details of the program will be posted on the Ontario Fencing Association website prior to selection.
- Designated rankings will be either Ontario High Performance ranking or the Canadian High Performance ranking as designated by the High Performance Committee in the selection criteria. In most cases, the most recent available designated ranking will be used to determine selection.
5. Athletes who wish to qualify for funding support must:
- be registered members in the current year of the Ontario Fencing Association (Excellence Leve) and a license holder of the Canadian Fencing Federation
- be registered in the appropriate Ontario High Performance Program
- be actively competing for Ontario
Types of Funding
1. Quest and other outside funding programs administered by the OFA
2. Subsidies for camps and other activities related to HP training
3. Bursaries and Prizes
4. Non-cash awards such as equipment and travel subsidies
5. Coach support at competitions and training events
Note: Not all categories of funding are available in any given year
Ontario Fencing High Performance Committee
Date: October 14, 2012
New OFA Policy Proposal: Transgendered Athletes wishing to compete in a OFA sanctioned event
The following policy clarifies participation of transgendered athletes undergoing Hormone Replacement Therapy (HRT) for a diagnosed Gender Identity Disorder (GID) and those not undergoing HRT, within competitions sanctioned by the Ontario Fencing Association (OFA).
1. A transgendered male (FemaleToMale or FTM) athlete taking medically prescribed HRT for a diagnosed Gender Identity Disorder may, for purposes of a competition sanctioned by the OFA, compete on a men’s team or male only competition, but is no longer eligible to compete on a women’s team or female only competition.
2. A transgendered female (MaleToFemale or MTF) athlete undergoing medically prescribed HRT for Gender Identity Disorder may, for the purposes of a competition sanctioned by the OFA, continue to compete on a men’s team or male competition but may not compete on a women’s team or competition until completing one calendar year of HRT.
3. Any transgendered athlete who is not undergoing HRT may participate in sex‐separated fencing events only in accordance with his or her assigned birth gender.
3a). A transgendered male (FTM) athlete who is not undergoing medically prescribed HRT related to gender transition may participate on a women’s team or competition.
3b). A transgendered female (MTF) athlete who is not undergoing HRT related to gender transition may participate on a men’s team or competition.
3c) In such cases, the transgendered athlete’s identity and dignity will be respected and that athlete will be protected from any form of discrimination from fellow competitors, organizers or judges, as per the OFA’s Harassment and Discrimination Policy.
The athlete’s responsibilities shall be:
- In order to avoid challenges to transgender participation, an athlete who has completed, or is in the process of undergoing HRT related to gender transition must submit a request to participate in an OFA sanctioned event in writing to the Executive Director (ED) of the OFA no less than 3 business days before competition. One request is sufficient for documentation and the athlete is not required to submit for subsequent participation unless there is a change in HRT or gender transition status.
- The request must include a letter from the athlete’s physician documenting the athlete’s transition status. This letter should identify the prescribed HRT for the athlete’s gender transition.
- Failure to provide documentation will exclude participation.
The Ontario Fencing Association’s responsibilities shall be:
- The Executive Director should review eligibility requirements and procedure for approval of transgender participation. If HRT is involved in the athlete’s transition, the Executive Director would make the athlete aware that the OFA endorses and has formally adopted the Canadian Anti‐Doping Program (CADP), which is compliant with the World Anti‐Doping Code. The CADP currently identifies testosterone as a banned substance (CADP Article 4.0 The Prohibited List), and outlines Therapeutic Use Exemption (TUE) rules (CADP Article 5.0 Therapeutic Use Exemption and Medical Review Rules) whereby an athlete must demonstrate the medical need for the use of a banned medication. It is the responsibility of the OFA to ensure compliance by its athletes to the CADP in terms of applicable Therapeutic Use Exemption rules (CADP Article 5.0 Therapeutic Use Exemption and Medical Review Rules). Under CADP Article 5.0, OFA athletes are eligible for a TUE obtained prior to the athlete competing while undergoing treatment or may go through a Medical Review process which is completed retroactively in the event of an Adverse Analytical Finding. The Medical Review process does not apply to athletes competing in certain national events outside of OFA sanction or to any international event.
- All discussions among involved parties and required written supporting documentation should be kept confidential and respect the OFA’s and the tournament’s organising body’s policies in respect to privacy and the collection of personal information, unless the athlete makes a specific request otherwise. All information about an individual’s transgender identity and medical information, including physician’s information provided pursuant to this policy, shall be maintained strictly confidentially.